Background:PERFORM-TSIXisamulticenter,internationaldiagnosticstudytoevaluatethediagnosticvalueofRoche'ssixthgeneration high-sensitivity troponin assay.PatientspresentingtotheemergencydepartmentoftheUniversityHospitalBaselwithchestpainorsuspectedacute coronarysyndromewillbeincluded.Bloodsamplesaretakenatentry,after1,2,3and6hours.After30and180days, the study participants are contacted for a follow-up.The study duration is planned for the period from 09.2022 to 10.2023Sponsor:RocheTrial Status:RecruitingEnrolling Centers:Worldwide:1700 participants (May 2023)Core Study Team Basel: